Ironwood Pharmaceuticals, Inc.

IRWDNASDAQHealthcare● Active

$3.29

$-0.02(-0.60%)

Market Cap$541576770

P/E Ratio—

52W High$5.78

52W Low$0.56

Avg Volume2.5M

Open$3.49

Beta0.24

Net Income Financials Revenue

Ironwood Pharmaceuticals, Inc. (IRWD) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IRWD · net income · updated Jun 8, 2026

Core profitability metrics

IRWD · net income · margin · TTM · CAGR

Net income was $24.0M for FY2025 (fiscal year ending 2025-12-31), up 2629.2% year-over-year. Net profit margin was 8.1%. Based on available data, Ironwood Pharmaceuticals, Inc. has been profitable since at least 2019.

FY2025 Net Income$24.0M▲ +2629.2% YoY

Trailing 12M (TTM)$102.2Mtrailing 4 quarters sum

Net Profit Margin8.1%$24.0M ÷ $296.2M

YoY Change+2629.2%—

5-Year CAGR-25.7%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · IRWD net income history · IRWD profit margin

Annual net income data

IRWD · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$24.0M▲ +2629.2%8.1%$296.2M

FY2024$880,000▲ +100.1%0.3%$351.4M

FY2023Loss−$1.00B▼ 672.5%-226.4%$442.7M

FY2022$175.1M▼ 66.9%42.6%$410.6M

FY2021$528.4M▲ +397.7%127.7%$413.8M

Net income vs peers (Healthcare)

IRWD vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Ironwood Pharmaceuticals, Inc.YOU

IRWD

$24.0M+2629.2%8.1%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Ironwood Pharmaceuticals, Inc. (IRWD) reported net income of $24.0M for FY2025 (fiscal year ending 2025-12-31), up 2629.2% year-over-year. The net profit margin was 8.1% — meaning the company kept $0.08 of every dollar of revenue as profit.

Based on available data, Ironwood Pharmaceuticals, Inc. has been profitable since at least 2019. Net income reached a peak of $528.4M in FY2021. Data available for 15 fiscal years.

Ironwood Pharmaceuticals, Inc.'s net profit margin was 8.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Ironwood Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from IRWD net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IRWD net income · 5 questions

Ironwood Pharmaceuticals, Inc. is profitable. The company reported net income of $24.0M for FY2025, a net profit margin of 8.1%. Net income was up 2629.2% year-over-year. Based on available data, Ironwood Pharmaceuticals, Inc. has been profitable since at least 2019.

is IRWD profitabledoes IRWD make a profitIRWD profitabilityIRWD profitable company

▸ Source: FMP /income-statement · GAAP · Ironwood Pharmaceuticals, Inc. · Ironwood Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026